A Multisite Electronic Health Record Integrated Remote Monitoring Intervention for Hypertension Improvement: Protocol for a Randomized Pragmatic Comparative Effectiveness Trial.
EHR
RCT
blood pressure
electronic health record
hypertension
hypertensive
improvement science
monitor
monitoring
randomized controlled trial
remote blood pressure monitoring
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
received:
12
04
2023
accepted:
19
07
2023
revised:
14
07
2023
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
epublish
Résumé
Hypertension is a major contributor to various adverse health outcomes. Although previous studies have shown the benefits of home blood pressure (BP) monitoring over office-based measurements, there is limited evidence comparing the effectiveness of whether a BP monitor integrated into the electronic health record is superior to a nonintegrated BP monitor. In this paper, we describe the protocol for a pragmatic multisite implementation of a quality improvement initiative directly comparing integrated to nonintegrated BP monitors for hypertension improvement. We will conduct a randomized, comparative effectiveness trial at 3 large academic health centers across California. The 3 sites will enroll a total of 660 participants (approximately n=220 per site), with 330 in the integrated BP monitor arm and 330 in the nonintegrated BP control arm. The primary outcome of this study will be the absolute difference in systolic BP in mm Hg from enrollment to 6 months. Secondary outcome measures include binary measures of hypertension (controlled vs uncontrolled), hypertension-related health complications, hospitalizations, and death. The list of possible participants will be generated from a central data warehouse. Randomization will occur after enrollment in the study. Participants will use their assigned BP monitor and join site-specific hypertension interventions. Cross-site learning will occur at regular all-site meetings facilitated by the University of California, Los Angeles Value-Based Care Research Consortium. A pre- and poststudy questionnaire will be conducted to further evaluate participants' perspectives regarding their BP monitor. Linear mixed effects models will be used to compare the primary outcome measure between study arms. Mixed effects logistic regression models will be used to compare secondary outcome measures between study arms. The study will start enrolling participants in the second quarter of 2023 and will be completed by the first half of 2024. Results will be published by the end of 2024. This pragmatic trial will contribute to the growing field of chronic care management using remote monitoring by answering whether a hypertension intervention coupled with an electronic health record integrated home BP monitor improves patients' hypertension better than a hypertension intervention with a nonintegrated BP monitor. The outcomes of this study may help health system decision makers determine whether to invest in integrated BP monitors for vulnerable patient populations. ClinicalTrials.gov NCT05390502; clinicaltrials.gov/study/NCT05390502. PRR1-10.2196/45915.
Sections du résumé
BACKGROUND
BACKGROUND
Hypertension is a major contributor to various adverse health outcomes. Although previous studies have shown the benefits of home blood pressure (BP) monitoring over office-based measurements, there is limited evidence comparing the effectiveness of whether a BP monitor integrated into the electronic health record is superior to a nonintegrated BP monitor.
OBJECTIVE
OBJECTIVE
In this paper, we describe the protocol for a pragmatic multisite implementation of a quality improvement initiative directly comparing integrated to nonintegrated BP monitors for hypertension improvement.
METHODS
METHODS
We will conduct a randomized, comparative effectiveness trial at 3 large academic health centers across California. The 3 sites will enroll a total of 660 participants (approximately n=220 per site), with 330 in the integrated BP monitor arm and 330 in the nonintegrated BP control arm. The primary outcome of this study will be the absolute difference in systolic BP in mm Hg from enrollment to 6 months. Secondary outcome measures include binary measures of hypertension (controlled vs uncontrolled), hypertension-related health complications, hospitalizations, and death. The list of possible participants will be generated from a central data warehouse. Randomization will occur after enrollment in the study. Participants will use their assigned BP monitor and join site-specific hypertension interventions. Cross-site learning will occur at regular all-site meetings facilitated by the University of California, Los Angeles Value-Based Care Research Consortium. A pre- and poststudy questionnaire will be conducted to further evaluate participants' perspectives regarding their BP monitor. Linear mixed effects models will be used to compare the primary outcome measure between study arms. Mixed effects logistic regression models will be used to compare secondary outcome measures between study arms.
RESULTS
RESULTS
The study will start enrolling participants in the second quarter of 2023 and will be completed by the first half of 2024. Results will be published by the end of 2024.
CONCLUSIONS
CONCLUSIONS
This pragmatic trial will contribute to the growing field of chronic care management using remote monitoring by answering whether a hypertension intervention coupled with an electronic health record integrated home BP monitor improves patients' hypertension better than a hypertension intervention with a nonintegrated BP monitor. The outcomes of this study may help health system decision makers determine whether to invest in integrated BP monitors for vulnerable patient populations.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT05390502; clinicaltrials.gov/study/NCT05390502.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
PRR1-10.2196/45915.
Identifiants
pubmed: 37902819
pii: v12i1e45915
doi: 10.2196/45915
pmc: PMC10644190
doi:
Banques de données
ClinicalTrials.gov
['NCT05390502']
Types de publication
Journal Article
Langues
eng
Pagination
e45915Subventions
Organisme : NIA NIH HHS
ID : K24 AG047899
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States
Informations de copyright
©David R Lee, Matthew Chenoweth, Linh H Chuong, Chad W Villaflores, Miguel Cuevas, Sitaram Vangala, Jeff Borenstein, Hannah Kwak, Chidinma Chima-Melton, Maria Han, Samuel A Skootsky, Therese Chan Tack, Linda Branagan, Heather Martin, Reshma Gupta, Linda Phan, Michael A Sanchez, Mina M Malaak, Anna Dermenchyan, Kandyce N Pearson, Marine Altunyan, Peter F Barakat, Ray Pablo, Catherine Sarkisian. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 30.10.2023.
Références
Health Aff (Millwood). 2009 Jan-Feb;28(1):75-85
pubmed: 19124857
PLoS Med. 2009 Apr 28;6(4):e1000058
pubmed: 19399161
Hypertension. 2021 Dec;78(6):1719-1726
pubmed: 34365809
Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e000057
pubmed: 31714813
Hypertension. 2020 Jun;75(6):1334-1357
pubmed: 32370572
Am J Hypertens. 2015 Oct;28(10):1209-21
pubmed: 25725092
BMJ. 2021 Jan 19;372:m4858
pubmed: 33468518
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Hypertens. 2012 Jul;30(7):1289-99
pubmed: 22499289
Lancet. 2010 Jul 17;376(9736):163-72
pubmed: 20619448
Hypertension. 2020 Dec;76(6):1667-1673
pubmed: 33012202
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet. 2023 Jun 17;401(10393):2041-2050
pubmed: 37156250
Hypertension. 2005 Jul;46(1):156-61
pubmed: 15939805
Hypertension. 2014 Apr;63(4):878-85
pubmed: 24243703
Blood Press Monit. 2002 Dec;7(6):293-300
pubmed: 12488648
JAMA. 2014 Aug 27;312(8):799-808
pubmed: 25157723
JAMA. 2002 Oct 9;288(14):1775-9
pubmed: 12365965
JAMA Intern Med. 2022 Oct 1;182(10):1025-1034
pubmed: 35969408
J Med Internet Res. 2015 Apr 01;17(4):e86
pubmed: 25842005
Int J Environ Res Public Health. 2021 Oct 09;18(20):
pubmed: 34682329
JAMA. 2021 Apr 27;325(16):1650-1656
pubmed: 33904861
Ann Med. 2010 Jul;42(5):371-86
pubmed: 20504241